Proteomic characterisation of the Chlamydia abortus outer membrane complex (COMC) using combined rapid monolithic column liquid chromatography and fast MS/MS scanning.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 01 08 2019
accepted: 01 10 2019
entrez: 25 10 2019
pubmed: 28 10 2019
medline: 20 3 2020
Statut: epublish

Résumé

Data are presented on the identification and partial characterisation of proteins comprising the chlamydial outer membrane complex (COMC) fraction of Chlamydia abortus (C. abortus)-the aetiological agent of ovine enzootic abortion. Inoculation with the COMC fraction is known to be highly effective in protecting sheep against experimental challenge and its constituent proteins are therefore of interest as potential vaccine candidates. Sodium N-lauroylsarcosine (sarkosyl) insoluble COMC proteins resolved by SDS-PAGE were interrogated by mass spectrometry using combined rapid monolithic column liquid chromatography and fast MS/MS scanning. Downstream database mining of processed tandem MS data revealed the presence of 67 proteins in total, including putative membrane associated proteins (n = 36), such as porins, polymorphic membrane proteins (Pmps), chaperonins and hypothetical membrane proteins, in addition to others (n = 22) that appear more likely to have originated from other subcellular compartments. Electrophoretic mobility data combined with detailed amino acid sequence information derived from secondary fragmentation spectra for 8 Pmps enabled peptides originating from protein cleavage fragments to be mapped to corresponding regions of parent precursor molecules yielding preliminary evidence in support of endogenous post-translational processing of outer membrane proteins in C. abortus. The data presented here will facilitate a deeper understanding of the pathogenesis of C. abortus infection and represent an important step towards the elucidation of the mechanisms of immunoprotection against C. abortus infection and the identification of potential target vaccine candidate antigens.

Identifiants

pubmed: 31647835
doi: 10.1371/journal.pone.0224070
pii: PONE-D-19-19899
pmc: PMC6812762
doi:

Substances chimiques

Bacterial Outer Membrane Proteins 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0224070

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/E018939/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Reprod Immunol. 2010 Feb;63(2):161-72
pubmed: 20064144
Proteomics. 2009 Mar;9(6):1720-6
pubmed: 19242933
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5011-5
pubmed: 8506346
Q J Med. 1985 Oct;57(222):689-96
pubmed: 4080958
Vaccine. 2009 Aug 6;27(36):5020-5
pubmed: 19446590
Infect Immun. 1990 Sep;58(9):3101-8
pubmed: 2387636
J Comp Pathol. 2003 May;128(4):217-44
pubmed: 12834606
Vet Microbiol. 2009 Mar 16;135(1-2):68-77
pubmed: 19054633
Microbiology. 2001 Nov;147(Pt 11):3135-40
pubmed: 11700364
Bioinformatics. 2010 Jul 1;26(13):1608-15
pubmed: 20472543
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14440-5
pubmed: 8962070
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
J Bacteriol. 1995 Feb;177(4):877-82
pubmed: 7532170
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Infect Immun. 1981 Mar;31(3):1161-76
pubmed: 7228399
Vet Microbiol. 2014 Dec 5;174(3-4):448-455
pubmed: 25457368
Mol Microbiol. 2005 Dec;58(5):1216-25
pubmed: 16313611
Rapid Commun Mass Spectrom. 2005;19(23):3420
pubmed: 16252315
Infect Immun. 1998 Apr;66(4):1317-24
pubmed: 9529048
Bioinformatics. 2014 May 1;30(9):1236-40
pubmed: 24451626
Mol Microbiol. 2011 Oct;82(1):131-44
pubmed: 21883523
Proteomics. 2005 Apr;5(6):1558-73
pubmed: 15838905
PLoS One. 2012;7(4):e35097
pubmed: 22506068
Infect Immun. 1997 Aug;65(8):3361-9
pubmed: 9234798
Infect Immun. 1998 Nov;66(11):5202-7
pubmed: 9784523
Vet Microbiol. 2012 Dec 7;160(3-4):525-9
pubmed: 22776512
Curr Opin Microbiol. 2001 Feb;4(1):16-20
pubmed: 11173028
PLoS One. 2007 Jun 27;2(6):e568
pubmed: 17593967
Vaccine. 1990 Aug;8(4):342-6
pubmed: 2396474
FEMS Immunol Med Microbiol. 2009 Mar;55(2):187-95
pubmed: 19187221
PLoS One. 2012;7(11):e49190
pubmed: 23145118
Br Med J (Clin Res Ed). 1985 Feb 23;290(6468):592-4
pubmed: 3918685
PLoS One. 2015 Jul 31;10(7):e0134418
pubmed: 26230848
Rapid Commun Mass Spectrom. 2006;20(14):2074-80
pubmed: 16773668
J Med Microbiol. 2007 Jan;56(Pt 1):15-22
pubmed: 17172511
PLoS One. 2013;8(2):e56292
pubmed: 23431368
Vet Microbiol. 1996 Feb;48(3-4):269-82
pubmed: 9054123
Genome Res. 2005 May;15(5):629-40
pubmed: 15837807
J Microbiol Immunol Infect. 2007 Jun;40(3):188-200
pubmed: 17639158
Trends Microbiol. 2007 Jun;15(6):241-51
pubmed: 17482820
Microbiol Mol Biol Rev. 1998 Jun;62(2):379-433
pubmed: 9618447
J Immunol. 2004 Dec 1;173(11):6905-13
pubmed: 15557186
Infect Immun. 2001 Apr;69(4):2428-34
pubmed: 11254603
Infect Immun. 2003 Feb;71(2):973-84
pubmed: 12540580
N Engl J Med. 1986 Jul 17;315(3):161-8
pubmed: 3724806
Vet Microbiol. 2013 May 3;163(3-4):207-22
pubmed: 22986056
Science. 1998 Oct 23;282(5389):754-9
pubmed: 9784136
Vet Res. 2009 Sep-Oct;40(5):47
pubmed: 19454212
Clin Vaccine Immunol. 2008 Dec;15(12):1824-33
pubmed: 18845834
FEMS Immunol Med Microbiol. 2008 Jul;53(2):222-30
pubmed: 18462389
FEMS Microbiol Lett. 2001 Sep 25;203(2):153-9
pubmed: 11583841
J Gen Microbiol. 1993 Dec;139(12):2965-72
pubmed: 7510322
Infect Immun. 1995 Dec;63(12):4912-6
pubmed: 7591155
DNA Res. 2006 Feb 28;13(1):15-23
pubmed: 16766509
Mol Microbiol. 2000 Nov;38(4):772-80
pubmed: 11115112
J Bacteriol. 2008 May;190(10):3757-67
pubmed: 18310329
J Bacteriol. 1996 Jan;178(1):1-5
pubmed: 8550401
Vet Microbiol. 1986 Sep;12(3):213-20
pubmed: 3776092
Infect Immun. 1984 Aug;45(2):384-9
pubmed: 6086526
N Engl J Med. 1975 Jun 5;292(23):1199-205
pubmed: 165407
FEMS Microbiol Lett. 1996 Sep 1;142(2-3):277-81
pubmed: 8810511
Infect Immun. 1994 Mar;62(3):880-6
pubmed: 7509320
Mol Microbiol. 2004 Jan;51(2):319-34
pubmed: 14756775
Infect Immun. 2009 Jan;77(1):508-16
pubmed: 19001072
Microb Pathog. 2000 Aug;29(2):63-72
pubmed: 10906261
Vaccine. 2004 Oct 22;22(31-32):4282-6
pubmed: 15474719
Nucleic Acids Res. 2003 Apr 15;31(8):2134-47
pubmed: 12682364
Chin Med J. 1957 Jun;75(6):429-47
pubmed: 13461224
J Bacteriol. 2010 Jun;192(11):2852-60
pubmed: 20348250
Methods Mol Biol. 2017;1611:59-73
pubmed: 28451972
Mol Microbiol. 2008 Jan;67(2):403-19
pubmed: 18086188
Trends Microbiol. 2001 Dec;9(12):573-8
pubmed: 11728862

Auteurs

David Longbottom (D)

Moredun Research Institute, Pentlands Science Park, Edinburgh, United Kingdom.

Morag Livingstone (M)

Moredun Research Institute, Pentlands Science Park, Edinburgh, United Kingdom.

Kevin D Aitchison (KD)

Moredun Research Institute, Pentlands Science Park, Edinburgh, United Kingdom.

Lisa Imrie (L)

Moredun Research Institute, Pentlands Science Park, Edinburgh, United Kingdom.

Erin Manson (E)

Moredun Research Institute, Pentlands Science Park, Edinburgh, United Kingdom.

Nicholas Wheelhouse (N)

Moredun Research Institute, Pentlands Science Park, Edinburgh, United Kingdom.

Neil F Inglis (NF)

Moredun Research Institute, Pentlands Science Park, Edinburgh, United Kingdom.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH